Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease

Gut microbiota influences the clinical response of a wide variety of orally administered drugs. However, the underlying mechanisms through which drug–microbiota interactions occur are still obscure. Previously, we reported that tyrosine decarboxylating (TDC) bacteria may restrict the levels of levod...

Descripción completa

Detalles Bibliográficos
Autores principales: van Kessel, Sebastiaan P., Auvinen, Petri, Scheperjans, Filip, El Aidy, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674283/
https://www.ncbi.nlm.nih.gov/pubmed/34911958
http://dx.doi.org/10.1038/s41531-021-00260-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674283/
https://www.ncbi.nlm.nih.gov/pubmed/34911958
http://dx.doi.org/10.1038/s41531-021-00260-0

Ejemplares similares